taselisib (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
taselisib
Taselisib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/taselisib/Taselisib/pm42001845-28-0-7
Average 94 stars, based on 20 article reviews
Taselisib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/taselisib/Taselisib/pm42001845-28-0-7
Average 94 stars, based on 20 article reviews
taselisib - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Radial Immuno Diffusion:Article Title: Cancer-associated fibroblast miR-148a-5p/CALD1/collagen VI pathway promotes proliferation in Helicobacter pylori-positive gastric cancer. Article Snippet: Primary CAFs isolated in-house were employed solely in Fig. 2, E and F. Hp-stimulated CAFs、 are Hp strain PMSS1 were purchased from Biobw, Beijing, China and was added to the medium at a MOI from 10 to 100 for 6 to 24 h. Antagonists used were listed as follows: Afimetoran (TLR, MCE, CAS No. 2171019-55-7, 1 μM); NOD1/2 antagonist-1 (NOD1/2, MCE, CAS No. 2704623- 69-6, 5 μM [11]). .. Pathway inhibitors used were listed as follows: IMD-0354 (NFκB, MCE, CAS No. 978-62-1, 1 μM); p38 MAP Kinase Inhibitor III (MAPK, MCE, CAS No. 581098-48-8, 1 μM); Article Title: Cancer-associated fibroblast miR-148a-5p/CALD1/collagen VI pathway promotes proliferation in Helicobacter pylori -positive gastric cancer Article Snippet: Primary CAFs isolated in-house were employed solely in Fig. , E and F. Hp-stimulated CAFs、 are Hp strain PMSS1 were purchased from Biobw, Beijing, China and was added to the medium at a MOI from 10 to 100 for 6 to 24 h. Antagonists used were listed as follows: Afimetoran (TLR, MCE, CAS No. 2171019-55-7, 1 μM); NOD1/2 antagonist-1 (NOD1/2, MCE, CAS No. 2704623-69-6, 5 μM [ ]). .. Pathway inhibitors used were listed as follows: IMD-0354 (NFκB, MCE, CAS No. 978-62-1, 1 μM); p38 MAP Kinase Inhibitor III (MAPK, MCE, CAS No. 581098-48-8, 1 μM); |